Zevenbergen Capital Investments LLC lowered its stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 3.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 198,275 shares of the technology company’s stock after selling 6,668 shares during the period. Veeva Systems comprises 1.1% of Zevenbergen Capital Investments LLC’s investment portfolio, making the stock its 27th biggest position. Zevenbergen Capital Investments LLC owned about 0.12% of Veeva Systems worth $59,068,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Trust Co. of Toledo NA OH purchased a new stake in Veeva Systems during the 2nd quarter worth approximately $29,000. Legacy Investment Solutions LLC acquired a new stake in shares of Veeva Systems in the second quarter worth approximately $32,000. Maseco LLP acquired a new stake in shares of Veeva Systems in the second quarter worth approximately $35,000. Cary Street Partners Investment Advisory LLC increased its position in shares of Veeva Systems by 58.3% during the second quarter. Cary Street Partners Investment Advisory LLC now owns 133 shares of the technology company’s stock worth $38,000 after purchasing an additional 49 shares in the last quarter. Finally, Elevation Point Wealth Partners LLC acquired a new position in Veeva Systems in the 2nd quarter valued at $41,000. 88.20% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Veeva Systems
In other news, SVP Jonathan Faddis sold 720 shares of the firm’s stock in a transaction on Monday, October 6th. The stock was sold at an average price of $298.12, for a total transaction of $214,646.40. Following the completion of the transaction, the senior vice president directly owned 7,868 shares in the company, valued at $2,345,608.16. This trade represents a 8.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of Veeva Systems stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $306.62, for a total value of $1,839,720.00. Following the completion of the sale, the insider directly owned 25,325 shares of the company’s stock, valued at $7,765,151.50. The trade was a 19.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 24,665 shares of company stock worth $7,438,000. Insiders own 10.30% of the company’s stock.
Analyst Upgrades and Downgrades
Get Our Latest Stock Analysis on Veeva Systems
Veeva Systems Stock Performance
Shares of Veeva Systems stock opened at $222.11 on Friday. The stock has a 50 day moving average of $265.47 and a 200 day moving average of $276.91. The firm has a market capitalization of $36.51 billion, a price-to-earnings ratio of 43.21, a PEG ratio of 1.62 and a beta of 1.05. Veeva Systems Inc. has a fifty-two week low of $201.54 and a fifty-two week high of $310.50.
Veeva Systems (NYSE:VEEV – Get Free Report) last posted its earnings results on Thursday, November 20th. The technology company reported $2.04 EPS for the quarter, beating analysts’ consensus estimates of $1.95 by $0.09. The company had revenue of $0.81 million for the quarter, compared to the consensus estimate of $792.37 million. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.The company’s revenue for the quarter was up 16.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.75 earnings per share. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. Analysts forecast that Veeva Systems Inc. will post 4.35 EPS for the current year.
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Read More
- Five stocks we like better than Veeva Systems
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- This ETF Caught a Major Tailwind After the Fed’s Rate Cut
- The How And Why of Investing in Oil Stocks
- MarketBeat Week in Review – 12/15 – 12/19
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Nike Beats on Earnings But Struggles in China and Faces Tariffs
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
